HIRONC

HIRONIC Co., Ltd a leading company in energy-based medical aesthetic devices, showcased its new product SYNERJET PRO™ at Dubai Derma 2025, the largest medical aesthetics exhibition in the Middle East.

At the event, HIRONIC introduced SYNERJET PRO™, a needle-free drug delivery device, as its flagship product. The system combines Micro-Jetting, Electroporation, and Plasma technologies to deliver active ingredients uniformly into the dermal layer.

Designed to minimize the discomfort and psychological burden associated with traditional needle injections, SYNERJET PRO™ drew attention for its potential application in various areas such as skin boosters and anti-aging treatments. During the exhibition, the product received positive feedback from local medical professionals, who noted its strong alignment with the growing demand in the Middle Eastern medical aesthetics market.

Prior to Dubai Derma, HIRONIC had already introduced SYNERJET PRO™ at several major international exhibitions, including IMCAS Paris 2025 in January and AAD and KIMES 2025 in March.

“The SYNERJET PRO™ is one of HIRONIC’s next-generation global strategy products, developed to overcome the technical limitations of previous needle-free injectors,” said a HIRONIC representative in charge of the Middle East region. “The enthusiastic response at Dubai Derma has reinforced our confidence in both the product strategy and brand direction.”

HIRONIC is also scheduled to participate in IMCAS Asia 2025, to be held this June in Bangkok, where the company will conduct live demonstrations and academic sessions centered on SYNERJET PRO™.